Article Details

AstraZeneca betting on China's PD-1 cancer market

Retrieved on: 2021-03-01 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca betting on China's PD-1 cancer market. View article details on hiswai:

Excerpt

AstraZeneca has signed a deal with Chinese biotech, Junshi Biosciences, to market its cancer immunotherapy. The British-Swedish pharma company ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up